BRIEF-Gilead Sciences To Acquire Arcellx To Maximize Long-Term Potential Of Anito-Cel
BRIEF-<a href="https://laohu8.com/S/GILD">Gilead</a> Sciences To Acquire Arcellx To Maximize Long-Term Potential Of Anito-CelArcellx Inc ACLX.O:
GILEAD SCIENCES TO ACQUIRE ARCELLX TO MAXIMIZE LONG-TERM POTENTIAL OF ANITO-CEL
GILEAD - TO BUY ARCELLX FOR $115 PER SHARE IN CASH
GILEAD - DEAL REPRESENTS IMPLIED EQUITY VALUE OF $7.8 BILLION
GILEAD - DEAL EXPECTED TO BE ACCRETIVE TO EPS IN 2028 AND THEREAFTER
Source text: ID:nBw9F864Ha
Further company coverage: ACLX.O
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。